Newsroom Spotlight Story UCB’s Catherine Rives and Alexandria Harrold Recognized by Healthcare Businesswomen’s Association (HBA) as Luminary and Rising Star Read more Press Releases UCB Launches Career-Advancing Scholarship Program for Adults Living with Hidradenitis Suppurativa… Read More BIMZELX® (bimekizumab-bkzx) demonstrates superior efficacy over SKYRIZI® (risankizumab-rzaa) in… Read More UCB to acquire Candid Therapeutics, building upon its existing immunology pipeline with novel T-… Read More UCB to acquire Neurona Therapeutics, advancing its innovative leadership in epilepsy through… Read More UCB presents new data demonstrating quality-of-life impacts for epilepsy patients and caregivers at… Read More UCB announces new clinical data from its generalized myasthenia gravis (gMG) portfolio at the 2026… Read More UCB Stories Supporting Families During Dravet Syndrome Awareness Month: A look into Camp Small Steps Read More Running Toward Relief: How Cassie is Reclaiming Her Life With Psoriatic Arthritis Read More UCB Issues Voluntary Recall of Select Lots of CIMZIA® Pre-Filled Syringes (PFS) in the United States Read More UCB’s Catherine Rives and Alexandria Harrold Recognized by Healthcare Businesswomen’s Association… Read More Evolving Expectations in Immunologic Disease: Our work with those living with immune-mediated… Read More 3 in 3: Advancing hope for rare and ultra-rare disease communities, one innovation at a time Read More View all Subscribe For More Information Media Contact Speaker Requests Connect with Us on Social @UCBUSA Instagram @UCBUSA X (formerly Twitter) UCB LinkedIn UCB Facebook UCB USA YouTube UCB IN THE U.S. U.S. Leadership PATIENTS
Spotlight Story UCB’s Catherine Rives and Alexandria Harrold Recognized by Healthcare Businesswomen’s Association (HBA) as Luminary and Rising Star Read more